Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|
Hill Path Capital LP | 20.6% | +11.1% | $125M | 7.12M | 0% | Hill Path Capital LP | Apr 7, 2025 | |
BlackRock, Inc. | 12.1% | $82.4M | 4.67M | BlackRock, Inc. | Mar 31, 2025 | |||
VANGUARD GROUP INC | 8.81% | -15.3% | $65.5M | -$11.2M | 3.05M | -14.6% | The Vanguard Group | Jun 30, 2025 |
EMINENCE CAPITAL, LP | 7.5% | $51.2M | 2.91M | Eminence Capital, LP | Mar 31, 2025 | |||
Patient Capital Management, LLC | 5.72% | $38.8M | 2.2M | Patient Capital Management, LLC | Mar 31, 2025 |
Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
---|---|---|---|---|---|
2025 Q3 | 99.6K | $1.81M | -$80.4K | $18.16 | 3 |
2025 Q2 | 40.3M | $1.21B | -$129M | $30.08 | 189 |
2025 Q1 | 45.6M | $801M | -$84.9M | $17.57 | 184 |
2024 Q4 | 48.6M | $1.42B | +$2.48M | $29.19 | 190 |
2024 Q3 | 48.1M | $1.64B | +$61M | $34.05 | 223 |
2024 Q2 | 46.2M | $1.84B | -$95.6M | $39.81 | 223 |
2024 Q1 | 46.5M | $2.91B | +$198M | $62.60 | 234 |
2023 Q4 | 85.1K | $4.58M | +$3.8M | $53.85 | 2 |
2023 Q3 | 43.6M | $1.62B | -$21M | $37.07 | 201 |
2023 Q2 | 43.8M | $1.95B | -$233M | $44.56 | 207 |
2023 Q1 | 50.1M | $1.84B | -$15.4M | $36.79 | 219 |
2022 Q4 | 50.9M | $1.81B | +$40.8M | $35.44 | 221 |
2022 Q3 | 48.6M | $1.51B | +$38.1M | $31.03 | 204 |
2022 Q2 | 48.2M | $1.58B | -$50.9M | $32.78 | 215 |
2022 Q1 | 46.7M | $2.28B | +$180M | $49.10 | 232 |
2021 Q4 | 42.8M | $1.64B | -$74.1M | $38.40 | 201 |
2021 Q3 | 45.1M | $1.73B | +$16.7M | $38.33 | 193 |
2021 Q2 | 45.1M | $1.83B | -$144M | $40.60 | 204 |
2021 Q1 | 48.2M | $2.31B | -$32.8M | $47.90 | 210 |
2020 Q4 | 49.2M | $1.48B | +$89.8M | $30.02 | 167 |
2020 Q3 | 47.1M | $715M | +$105M | $15.16 | 149 |
2020 Q2 | 38.7M | $516M | +$84.1M | $13.33 | 150 |
2020 Q1 | 32.2M | $421M | -$128M | $13.08 | 142 |
2019 Q4 | 35.1M | $1.41B | -$63.4M | $40.17 | 194 |
2019 Q3 | 36.2M | $1.41B | -$218M | $38.95 | 195 |
2019 Q2 | 41.5M | $1.68B | -$34.3M | $40.47 | 224 |
2019 Q1 | 42.2M | $2.1B | -$77.3M | $49.87 | 241 |
2018 Q4 | 43.7M | $1.95B | -$66.1M | $44.56 | 233 |
2018 Q3 | 43.6M | $2.89B | +$127M | $66.22 | 251 |
2018 Q2 | 42.5M | $2.02B | -$137M | $47.60 | 218 |
2018 Q1 | 44.1M | $1.84B | -$49M | $41.74 | 233 |
2017 Q4 | 46.6M | $2.57B | +$72.5M | $55.17 | 246 |
2017 Q3 | 45.3M | $2.38B | -$30.1M | $52.48 | 244 |
2017 Q2 | 45.3M | $3.01B | +$6.91M | $66.51 | 243 |
2017 Q1 | 45.8M | $2.8B | +$324M | $61.09 | 226 |
2016 Q4 | 45.5M | $2.56B | +$45.8M | $56.30 | 225 |
2016 Q3 | 45.4M | $1.78B | +$29.2M | $39.18 | 183 |
2016 Q2 | 44.1M | $2.06B | +$54M | $46.79 | 199 |
2016 Q1 | 43.5M | $1.69B | +$141M | $38.78 | 162 |
2015 Q4 | 40.1M | $1.67B | +$206M | $41.74 | 161 |
2015 Q3 | 35.2M | $1.33B | -$184M | $37.83 | 137 |
2015 Q2 | 40M | $1.44B | +$22M | $36.09 | 138 |
2015 Q1 | 39.4M | $1.2B | -$74M | $30.46 | 86 |
2014 Q4 | 38.3M | $1.05B | +$1.05B | $27.30 | 59 |